{"id":"https://openalex.org/W7095941214","doi":null,"title":"Distribution Metabolism Excretion Gender Elderly","display_name":"Distribution Metabolism Excretion Gender Elderly","alternate_titles":[],"publication_year":null,"publication_date":null,"ids":{"openalex":"https://openalex.org/W7095941214"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.202.8944","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.202.8944","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.bccancer.bc.ca/NR/rdonlyres/eiuj46vxdnxp63uvwz2l5n53ylbuysvxkd2nmazwiu3x7syfopyfelgfnfbhio5d2btqorb2ebuk3k/Trastuzumabmonograph.pdf","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7095941214"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.7910000085830688},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor-2","display_name":"epidermal growth factor receptor 2","score":0.843999981880188},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6880000233650208},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.7929999828338623},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7680000066757202},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.5820000171661377},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.7179999947547913},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.8840000033378601},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.550000011920929},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.4399999976158142},{"id":"https://openalex.org/keywords/drug-excretion","display_name":"drug excretion","score":0.7369999885559082},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.6060000061988831},{"id":"https://openalex.org/keywords/gender-differences","display_name":"gender differences","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.6858999729156494},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6481000185012817},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6065000295639038},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.507099986076355},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.45249998569488525},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4462999999523163},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41620001196861267},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.4074000120162964},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4034000039100647},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37310001254081726},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3700999915599823},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.35929998755455017},{"id":"https://openalex.org/C197462201","wikidata":"https://www.wikidata.org/wiki/Q2476074","display_name":"Cell surface receptor","level":3,"score":0.3467999994754791},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.3456999957561493},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.34150001406669617},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.33719998598098755},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.33079999685287476},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33000001311302185},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.3287999927997589},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.32580000162124634},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.31290000677108765},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30239999294281006},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2985000014305115},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.271699994802475},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.27070000767707825},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.2694999873638153},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.26820001006126404},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.26589998602867126},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.2644999921321869},{"id":"https://openalex.org/C103474210","wikidata":"https://www.wikidata.org/wiki/Q142851","display_name":"Immune receptor","level":3,"score":0.2567000091075897},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.2529999911785126}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.202.8944","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.202.8944","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.bccancer.bc.ca/NR/rdonlyres/eiuj46vxdnxp63uvwz2l5n53ylbuysvxkd2nmazwiu3x7syfopyfelgfnfbhio5d2btqorb2ebuk3k/Trastuzumabmonograph.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2133105825","https://openalex.org/W7100618298","https://openalex.org/W7095390121","https://openalex.org/W2264655007","https://openalex.org/W197699128","https://openalex.org/W1972723779","https://openalex.org/W2093153734","https://openalex.org/W1998297552","https://openalex.org/W2123646476","https://openalex.org/W4381568581"],"abstract_inverted_index":{"CLASSIFICATION:":[0],"monoclonal":[1,24],"antibody,":[2],"noncytotoxic":[3],"Special":[4],"pediatric":[5],"considerations":[6],"are":[7,51,67],"noted":[8],"when":[9],"applicable,":[10],"otherwise":[11],"adult":[12],"provisions":[13],"apply.":[14],"MECHANISM":[15],"OF":[16],"ACTION:":[17],"Trastuzumab":[18],"is":[19,84],"a":[20],"recombinant":[21],"DNA-derived":[22],"humanized":[23],"antibody":[25],"based":[26],"on":[27],"human":[28,132],"immunoglobulin":[29],"G":[30],"(IgG).":[31],"It":[32],"binds":[33],"to":[34],"the":[35,38],"antigen":[36],"of":[37,72,81,100,104,108,117,123,131],"epidermal":[39],"growth":[40,126],"factor":[41,127],"receptor":[42],"2":[43,64,139],"(HER2).":[44],"Activated":[45],"HER2":[46,65,82,105],"(or":[47],"HER-2/neu,":[48],"c-erbB2)":[49],"receptors":[50,66,83],"involved":[52],"in":[53,69,87],"intracellular":[54],"tyrosine":[55],"kinases":[56],"that":[57],"mediate":[58],"cell":[59,113],"growth,":[60],"differentiation":[61],"and":[62,75,93,121],"survival.":[63],"overexpressed":[68],"25-30":[70],"%":[71],"breast":[73],"cancers":[74],"associated":[76],"with":[77],"poor":[78],"prognosis.":[79],"Overexpression":[80],"also":[85],"found":[86],"many":[88],"cancers,":[89],"including":[90],"lung,":[91],"ovarian,":[92],"prostate":[94],"cancers.":[95],"3":[96],"Possible":[97],"antiproliferative":[98],"mechanisms":[99],"trastuzumab":[101,135],"include":[102],"down-regulation":[103],"receptors,":[106],"activation":[107],"immune":[109],"effector":[110],"cells":[111],"(antibody-dependent":[112],"mediated":[114],"cytotoxicity),":[115],"reduction":[116,122],"S-phase":[118],"cell-cycle":[119],"progression,":[120],"vascular":[124],"endothelial":[125],"for":[128],"angiogenesis.":[129],"Development":[130],"antibodies":[133],"against":[134],"has":[136],"been":[137],"rare.":[138],"PHARMACOKINETICS:":[140]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7095941214","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2025-10-27T00:00:00"}
